Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pain, Intractable × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 256 Gastrointestinal Stromal Tumors 90 Neoplasms 87 Breast Neoplasms 77 Neoplasm Metastasis 63 Melanoma 62 Colorectal Neoplasms 61 Ovarian Neoplasms 60 Carcinoma, Non-Small-Cell Lung 60 Stomach Neoplasms 52 Osteosarcoma 51 Bone Neoplasms 48 Pancreatic Neoplasms 47 Prostatic Neoplasms 43 Sarcoma, Ewing 42 Glioblastoma 42 Lung Neoplasms 39 Head and Neck Neoplasms 37 Esophageal Neoplasms 37 Squamous Cell Carcinoma of Head and Neck 36 Lymphoma 36 Carcinoma, Renal Cell 35 Urinary Bladder Neoplasms 33 Sarcoma, Kaposi 32 Uterine Cervical Neoplasms 31 Lymphoma, Non-Hodgkin 31 Dendritic Cell Sarcoma, Interdigitating 31 Recurrence 30 Sarcoma, Synovial 29 Rhabdomyosarcoma 29

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡